, Tracking Stock Market Picks
Enter Symbol:

down 0.56 %

ONCOTHYREON (ONTY) rated Outperform with price target $15 by Wedbush

Posted on: Thursday,  Jun 23, 2011  9:25 AM ET by Wedbush

Wedbush rated Outperform ONCOTHYREON (NASDAQ: ONTY) on 06/23/2011. Previously Wedbush rated Outperform ONCOTHYREON (NASDAQ: ONTY) on 03/15/2011., when
the stock price was $3.55. Since then, ONCOTHYREON has lost 0.56% as of 01/14/2016's recent price of $3.53.
If you would have followed the previous Wedbush 's recommendation on ONTY, you would have lost 0.56% of your investment in 1766 days.

Oncothyreon Inc. (Oncothyreon) is a clinical-stage biopharmaceutical company. The Company focuses primarily on the development of therapeutic products for the treatment of cancer. The Company?s cancer vaccines are designed to stimulate the immune system to attack cancer cells, while its small molecule compounds are designed to inhibit the activity of specific cancer-related proteins. Oncothyreon?s lead product candidate is Stimuvax, which is a cancer vaccine in Phase III development for non-small cell lung cancer (NSCLC). Oncothyreon has an exclusive, worldwide license to Merck KGaA of Darmstadt, Germany (Merck KGaA), for the development, manufacture and commercialization of Stimuvax. Its pipeline of product candidates is consisted of cancer vaccines and small molecule candidates. The Company?s wholly owned subsidiaries include Oncothyreon Canada Inc., Biomira Management Inc., ProlX Pharmaceuticals Corporation, Biomira International Inc., Biomira BV and Oncothyreon Luxembourg.

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/23/2011 9:25 AM Buy
8.26 15.00
as of 12/30/2011
1 Week down  -1.30 %
1 Month up  8.59 %
3 Months up  26.75 %
1 YTD down  -8.23 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/15/2011 8:25 AM Buy
3.55 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy